Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.18 +0.02 (+1.11%) Closing price 07/3/2025 01:10 PM EasternExtended Trading$2.18 0.00 (-0.14%) As of 07/3/2025 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oramed Pharmaceuticals Stock Price Performance The Oramed Pharmaceuticals (ORMP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 14.02%, with a year-to-date return of -9.75%. In the past month, the stock has decreased 4.21%, reflecting recent market activity. As of the latest close, Oramed Pharmaceuticals traded at $2.18 with a market cap of $89.22 million and volume of 18,026 shares. Five years ago, the stock traded at $3.52, representing a 37.95% decrease over that period. At the time, it had a market cap of $81.01 million and a volume of 73,896 shares. Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.58%1 Month Performance-4.21%3 Month Performance+4.00%Year-To-Date Performance-9.75%1 Year Performance-14.02%5 Year Performance-37.95% ORMP Stock Chart for Friday, July, 4, 2025 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$2.16$2.18+1.11%$2.20$2.1618,026 shs$89.22 million07/02/2025$2.10$2.16+2.86%$2.19$2.1247,183 shs$88.24 million07/01/2025$2.25$2.10-6.67%$2.20$2.10117,830 shs$85.79 million06/30/2025$2.15$2.25+4.65%$2.25$2.11149,028 shs$91.91 million06/27/2025$2.17$2.15-0.92%$2.18$2.1059,111 shs$87.83 million06/26/2025$2.18$2.17-0.46%$2.19$2.1432,014 shs$88.64 million06/25/2025$2.17$2.18+0.46%$2.19$2.1326,985 shs$89.05 million06/24/2025$2.11$2.17+2.84%$2.21$2.07157,636 shs$88.64 million06/23/2025$2.13$2.11-0.94%$2.25$2.06141,792 shs$86.19 million06/20/2025$2.15$2.13-0.93%$2.17$2.0696,723 shs$87.01 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$2.15$2.15$2.20$2.1435,339 shs$87.83 million06/18/2025$2.16$2.15-0.46%$2.20$2.1435,339 shs$87.83 million06/17/2025$2.16$2.16$2.17$2.1423,221 shs$88.24 million06/16/2025$2.13$2.16+1.41%$2.17$2.1518,336 shs$88.24 million06/13/2025$2.24$2.13-4.91%$2.23$2.1242,954 shs$87.01 million06/12/2025$2.23$2.24+0.45%$2.26$2.1828,302 shs$91.50 million06/11/2025$2.23$2.23$2.27$2.2326,396 shs$91.10 million06/10/2025$2.23$2.23$2.28$2.2237,029 shs$91.10 million06/09/2025$2.22$2.23+0.45%$2.26$2.1841,289 shs$91.10 million06/06/2025$2.15$2.22+3.26%$2.25$2.0786,429 shs$90.69 million06/05/2025$2.28$2.15-5.70%$2.28$2.00356,648 shs$87.83 million06/04/2025$2.26$2.28+0.88%$2.30$2.2542,991 shs$93.14 million06/03/2025$2.38$2.26-5.04%$2.36$2.24124,880 shs$92.32 million Related Companies Terns Pharmaceuticals Stock Chart Arcturus Therapeutics Stock Chart Compass Therapeutics Stock Chart Astria Therapeutics Stock Chart SNDL Stock Chart Gossamer Bio Stock Chart MBX Biosciences Stock Chart Aquestive Therapeutics Stock Chart CryoPort Stock Chart Inventiva Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
